CAEYMAN, Aaron et al. Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis. Acta Oncologica, [S. l.], v. 65, p. 379–388, 2026. DOI: 10.2340/ao.v65.45460. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/45460. Acesso em: 22 may. 2026.